welcome
Investor's Business Daily

Investor's Business Daily

Business

Business & Economics

AbbVie Surges After Immunology Powerhouses Dominate — Again

Investor's Business Daily
Summary
Nutrition label

79% Informative

AbbVie ( ABBV ) stock surged early Friday after the pharma giant reported adjusted earnings of $ 2.16 per share on $15.1 billion in fourth-quarter sales.

Skyrizi revenue rocketed nearly 58% vs. the year-earlier period, while Rinvoq sales jumped more than 46% .

VR Score

86

Informative language

91

Neutral language

3

Article tone

formal

Language

English

Language complexity

25

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links